Astellas Enters into Collaborations with PeptiDream and Cullgen to Advance Targeted Protein Degraders

By Ashish Tripathi

Pharma Deals Review: Vol 2023 Issue 8 (Table of Contents)

Published: 8 Aug-2023

DOI: 10.3833/pdr.v2023.i8.2799     ISSN: 1756-7874

Section: Research & Development



In a bid to bolster its targeted protein degradation approach, Astellas has entered into a collaboration and licensing agreement with PeptiDream worth up to US$312...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details